跳至主要内容
临床试验/NCT05598931
NCT05598931已完成不适用

Development of Neuro-Navigated Transcranial Magnetic Stimulation (TMS) Using MRI

Soterix Medical1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2021年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
20
试验地点
1
主要终点
Brain Coordinates

研究概览

简要总结

Healthy controls (HC) will be studied once to provide data needed to validate the virtual neuro-navigation system. All subjects will undergo a single MRI session and will then participate in an on-line neuro-navigation session in which various TMS coil positions will be recorded. The brain/head images will be provided to the programmer to permit development of the virtual neuro-navigation algorithm. Data from Yr1 will be used by the programmer as a training sample, and from Yr2 as a test sample.

详细描述

HC subjects (n=10)/yr will be studied once to provide data needed to validate the virtual neuro-navigation system. All subjects will undergo a single Human Connectome Project compatible MRI session permitting application of both surface-based and more standard volumetric analyses. Subjects will then participate in an on-line neuro-navigation session in which TMS coil positions (in 10/20 coordinate space) will be recorded corresponding to the following targets: 1) hand-representation of motor strip; 2) 5-cm location; 3) 5.5 cm location; 4) MNI coordinates corresponding to the "Fitzgerald"4 and "Weigand"6 volumetric targets; 5) peak anti-correlated region (calculated from rsfcfMRI data alone); 6) center of our targeted parcel, calculated using surface-based approaches. The brain/head images will be provided to the programmer to permit development of the virtual neuro-navigation algorithm. Data from Yr1 will be used by the programmer as a training sample, and from Yr2 as a test sample. The Go/No-go criterion is an interclass correlation coefficient (ICC) of >.9 between scalp coordinates determined by on-line neuro-navigation and those determined virtually

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Non-depressed subjects

排除标准

  • Ever met criteria for a psychotic disorder (Sz, SzAff, Bipolar disorder); anorexia nervosa or bulimia nervosa within the last year
  • Unstable medical condition by history, physical exam or laboratory results
  • Contraindications to MRI (based on metal screening form)
  • Meets criteria for claustrophobia
  • Recent drug or alcohol use disorder with DSM-5 specifier of moderate or severe within 6 months, or mild within 2 months; lifetime history of IV drug use
  • A neurological or neuromuscular disorder;
  • Require medications for a general medical condition that contraindicate the TMS treatment
  • History of ketamine treatment within 6 mo
  • History of monoamine oxidase inhibitor (MAOI) within the past month
  • Lacks capacity to consent
  • Taking medications that increase the risk of seizures. For patients on permitted concomitant psychotropic agents (antidepressants, anticonvulsants, benzodiazepines, hypnotics, opiates, triiodothyronine (T3), modafinil, psychostimulants, buspirone, melatonin, omega-3 fatty acids, folate, lmethylfolate, s-adenosyl methionine, lithium) dosing must be stable for at least four weeks prior to study entry

结局指标

主要结局

Brain Coordinates

时间窗: Day 1

MRI based brain coordinates will be determined using newly developed neuronavigation software

次要结局

未报告次要终点

研究者

发起方
Soterix Medical
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验